chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had the second Covid-19 Moderna injection on 3/13. Three days later I woke up with "Covid arm." Palm-sized red warm spot 3 inches below injection site, which sometimes itches. Benadryl cream helps. Online news indicates it is rare, usually showing up 7-10 days after 1st injection, with fewer having it after the second. So my pattern is rarer still in that it began after the second shot but came 3 days after.  I was relieved that it is not serious and will go away on its own. If science learns more that has implications for future injections, I'd appreciate being informed. Thank you.
Subsequent to receiving vax, the pt developed a rash at the injection site. The reporter noted that Engerix B was administered to six pts all of whom developed a rash. In some cases, the rash extended to include the arm only, or the arm face, and trunk or the whole body. The most recent information received reports the outcome of the rash as resolved after 1-2 weeks.
I first noticed a rash; I didn't know what it was at first. I didn't know if it was eczema or psoriasis. I went to see a dermatologist and she confirmed it was eczema. She wanted to start me on a medication, that cost $5000 but my medical insurance was giving me issues at the time, so I had to wait from January all the way to July to get it and it had been getting worse. She finally started treating me and the eczema was changing the pigment of the skin. It itches all over arms, back of knees, elbows, and hands. She was giving me a 300ml injection of Dupixent. The itching didn't subside until about 1 and a half later. Now I'm self-administering the medication every two weeks. She also put me on Triamcinolone acetonide and  Pimecrolimus. I received many other vaccines and have never had a reaction like this.
Fever, intense chills and then sweat/chills throughout 1st night. Super bad headache at 3:00am and then lip swelling started - by 9:00am they were enormous.
pain at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77 year-old male patient received bnt162b2 (BNT162B2), administration date 26Feb2021 (Batch/Lot number: unknown) at the age of 77 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for Covid-19 Immunisation. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "pain at the injection site".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
78 yom presented to our ER w/complaints of fever and generalized weakness over 4 days. Received 4th dose the day prior to symptoms starting. Platelet count = 48 on admission to hospital facility and continued to decline. Patient mental status  progressively worsened.  CT of head on day 2 of admission was clear but on day 7, as mentation become profoundly worse, repeat CT showed diffuse right cerebral subdural hematoma (pt was never placed on anticoagulation or chemical thromboprophylaxis due to hematology results throughout stay). Midline shift of 1.9cm noted as a result.
Pt had a fever for 1 day, post vax. She also was on Amoxicillin for Otitis for 1 week. On 11/8/01, she developed a papular (? urticarial) rash. She was seen and treated with Atarax. Recovery is ongoing.
Generalized tonic-clonic seizures - Ativan, Phenbarb, fever 101.8F - ICU admission. R otitis media. Per follow up report-Epilepsy, intractable, mixed type. A temperal, but not necessarily caused, relationship has been established between the above vaccinations and the patients seizures. The shots were the second set received. Subsequent seizure episodes were usually, but not always, heralded by febrile viral illness.
Right arm swollen with red streaks, rash on body, given Benadryl. Mom states child had allergic reaction, fever 102.7F, hospitalized and given antibiotics. DC DX: Abdominal wall abscess times 2. HX: One week after chicken pox vaccine mom noticed several pox over the body including the lower abdomen. This area developed cellulitis. Initially treated by PCP with p.o. Clinidamycin. Seen in ED for increased cellulitis. In ED patient had erythema over lower mid-abdomen extending to her left hip and some mild induration without obvious abscess. Admitted for IV antibiotic therapy. Hospital Course: IV Clindamycin. After 1 day erythema had much resolved over infraumbilical region. After 2 days erythema had resolved, however, induration over infraumbilical region. In operating room incision and drainage was performed and another abscess on right flank regions of her abdomen was identified and incised and drained. Both areas packed, following day packing removed. Erythema resolved. Minimal bruising in inframumbilical region. Temp on admission 103. 10/13/06-records for DOS 5/10/06  c/o fever now at ER 99.7, runny nose, congestion, sore throat, cough vomiting times 2. DX pharyngitis strep positive.
Noticeable Erythematous patch about 50-70mm, slightly raised, warm and tender to touch on 09/24/2023
The biggest thing I noticed was a burning sensation in my eyes after the vaccination. On January 7, 2022, I started experiencing body aches. My boyfriend tested positive for COVID-19 on January 7, 2022. I felt the burning sensation in my eyes again. I also had a sore throat, runny nose, and a cough. I took a COVID-19 test through the drive-thru on January 7, 2022. My result was negative.
Shortly after receiving vaccinations, the pt and her father were driving out of the parking lot. The pt's head went back and she passed out in the car. The pt's father carried her in. The parents laid her down, she was seizing. Ammonia inhalants were used two times. The pt regained consciousness and complained of nausea. Her BP was 114/59, pulse was 67 and temp was 96.9. Later the pt vomited and then states "I feel better". The pt left the clinic with no problems.
PATIENT CAME ON SATURDAY 3/19/2022 AROUND 5PM TO PHARMACY ASKING TO GET A COVID BOOSTER SHOT. HE SHOWED A TECHNICIAN AT DROP OFF CDC CARD WITH 2 PFIZER DOSES ON 8/6/2021 AND 8/28/2021 IN PHARMACY. A TECHNICIAN PULLED PATIENT'S PROFILE IN STORE; PROFILE SHOWED THAT HE GOT 2 DOSES OF MODERNA ON 9/29/21021 AND 10/30/2021. AFTER TALKING TO PATIENT, HE TOLD  THAT HE HEARD FROM CDC THAT HE CAN MIX-AND-MATCH COVID SHOTS. I TRIED TO EXPLAIN TO HIM THAT ONLY COVID BOOSTER SHOTS CAN BE DIFFERENT FROM PRIMARY SERIES. I SUGGESTED HIM THAT HE NEEDS TO TALK TO HIS DOCTOR ABOUT COVID BOOSTER SHOT, WHICH ONE (IF ANY) HE CAN GET.
Headache, nausea, joint, muscle pain.  Low grade temperature of 99.8-100.8.  Oral and tympanic. Tender to palp along base of skull, spine and ribs.  Decreased range of motion of neck due to pain.
Initial adverse events feeling hot, dizziness, Event resolved 20-30 minutes post vaccination. Later experienced black tarry stools, low WBC, low RBC, high bilirubin levels, and loss of appetite.
Increase body pain and extreme fatigue, a flare-up of FM and ME, the worst part was my brain felt like it was swelling - not a headache - but pressure like it was swelling
Started having numbness and tingling in my left foot the next day after taking the vaccine. It lasted about a week after taking the vaccine. Never did seek medical treatment but discussed the side effect with my physician Dr  and decided not to take the second vaccine due to the side effect I had. I also discussed this side effect with the Infection Control nurse at my work place. I discussed with the Infection control nurse that after taking the 1st vaccine and having this reaction I didn't want to take the second vaccination.  I received the covid vaccination at my work place.
According to patient, some-time after receiving the Janssen vaccination on 09.13.2021, he began experiencing pain in his arm of the vaccination site.  He describes the pain as a minor, constant ache that worsens or is more prominent when in a seated position compared to laying.  He has been to his doctor several times and has had to schedule an MRI.
Received my second booster shot on Wednesday afternoon 1/11/2023 woke up Sunday morning with drooping right side of face went to ER on Monday the 16th of January, was told I have Bells Palsy put on Steroids
9-27-13 Feverish, lethargic. 9-28-13 Gradual worsening-dizziness-nausea. 9-29-13 Rash hives breathing difficulties body aches chills. All continued till 10-8-13 when I finally started to feel human again.
Acute onset of wheezing approx 10 minutes post vaccine administered nebulized albuterol given.
Fever, Chills, Body Aches, Headache.  Treatment with round the clock alternating tylenol and ibuprofen. Symptoms lasted 2 days. HEADACHE IS constant Unrelieved By above medications.
p/vax pt had rash; at least 100 bumps; white head bumps; no blisters; T101 for one day; rash itching
This spontaneous report as received from a pharmacist refers to a 12 year old patient of unknown gender. On 23-MAR-2013, the patient was vaccinated with a second dose of expired GARDASIL (lot number was reported as 12717, expiry date was 11-DEC-2012, dose and route was not reported). Additional information has been requested.
strong body aches after booster; chills after booster; headache after booster; vomiting; nausea; fever 99.7°F; not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well), MYALGIA (strong body aches after booster), CHILLS (chills after booster), PYREXIA (fever 99.7°F) and HEADACHE (headache after booster) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045J21A, 026B21A and 021C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, the patient experienced MALAISE (not feeling well), PYREXIA (fever 99.7°F) and NAUSEA (nausea). On 06-Dec-2021, the patient experienced VOMITING (vomiting). On an unknown date, the patient experienced MYALGIA (strong body aches after booster), CHILLS (chills after booster) and HEADACHE (headache after booster). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 04-Dec-2021, MALAISE (not feeling well) had resolved. On 05-Dec-2021, NAUSEA (nausea) had resolved. At the time of the report, MYALGIA (strong body aches after booster), CHILLS (chills after booster), PYREXIA (fever 99.7°F), HEADACHE (headache after booster) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Dec-2021, Body temperature: 99.7 (High) 99.7°F.         No concomitant medications were reported.  On Dec-2021 patient experienced strong body aches, chills and headache.   This case was linked to MOD-2021-405666, MOD-2021-405674 (Patient Link).
I had muscle stiffness of my neck and shoulder.  I have permeant headache since April.  I have full body hives.  They will go away from one spot to another spot.  I feel that I am not ever going to get rid of these hive and muscle stiffness and headache.  I went to my doctor about this.  They did a blood test for Lime disease and many other diseases.  This feels like I it is going to kill me.
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 76-year-old male patient who received SHINGRIX for prophylaxis. On 5th March 2019, the patient received the 2nd dose of SHINGRIX. In March 2019, less than a week after receiving SHINGRIX, the patient experienced injection site erythema, pain and tiredness. On an unknown date, the outcome of the injection site erythema, pain and tiredness were recovered/resolved. It was unknown if the reporter considered the injection site erythema, pain and tiredness to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the wife of the patient. The patient experienced some pinkness around the injection site, achiness and tiredness that went away after a couple of days. This case has been linked with the case US2019044309, reported by same reporter.
I am experiencing the same adverse events that carried over from the first dosage of the vaccine (hives) and currently being treated for the hives by my Doctor.
Initial and follow-up information has been received from a nurse practitioner (N.P.) concerning a 65 year old female with sulfonamide allergy, penicillin allergy, iodine allergy and an unspecified drug hypersensitivity to ibuprofen, aspirin and PERCOCET who on 01-MAY-2008 at 3:30 PM was vaccinated with ZOSTAVAX (Oka/Merck) (lot no. 659614/0161X) in her left upper arm.  The patient had hypothyroidism at the time of vaccination.  On approximately 04-APR-2008, "four weeks prior", the patient was vaccinated with pneumococcal vaccine (MSD).  Concomitant therapy included ESTRADERM, levothyroxine and hydroxyzine and prednisone.  On 15-MAY-2008 the patient experienced injection-site redness, pain and swelling.  The patient also developed an injection-site "knot" which was the size of an "avocado".  The patient also experienced a facial rash characterized as "small blisters".  Subsequently, the patient was treated by primary care provider in emergency room and was hospitalized.  At the time of this report, the patient's symptoms persisted.  Additional information is not expected.
Heart rate elevated to 188 hours after receiving the vaccine. Normally ranges around 55-60.
This spontaneous report as received from registered nurse refers to a 55 year old patient of an unknown gender. There was no information about the patient's concurrent conditions, medical history, any known allergies or reactions or concomitant medications. On 04-MAY-2017, the patient was vaccinated with improperly stored PNEUMOVAX 23 lot # N005096 with expiration date of 22-OCT-2018, for prophylaxis (dose and route of administration were not reported). The vaccine was exposed to a temperature excursion of 28 degrees Fahrenheit (°F) for 12 hours. There were not previous excursions or data logger involved. No adverse symptoms were reported. No product quality complaint was involved. No further information was provided. Additional information has been requested.
Initial report was received from a healthcare professional on 13 November 2012. An 8-year-old male patient received an injection in the left arm of FLUZONE, lot number U4481CC, on 20 October 2012 (route of administration not reported). On 10 November 2012, the patient experienced body aches, fever, and increased temperature. The patient required doctor visit and tested positive for type B. The test BIMAX NOW card was used to test the mucous. Patient's past medical history was unknown. The patient had no illness at time of vaccination. The patient's outcome was not recovered. Documents held by sender: None.
Lt. thigh skin: 8 cm. area of slight erythema and almost appears ecchymotic.  Evening of 5-22-08 - patient was "not consolable".
arm pain at site of injection; This spontaneous case was reported by a non-health professional and describes the occurrence of INJECTION SITE PAIN (arm pain at site of injection) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced INJECTION SITE PAIN (arm pain at site of injection). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, INJECTION SITE PAIN (arm pain at site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       concomitant medication information not provided.
Patient had a temperature of 102.3 to 100.9 on 07/24/2005.  Dad said the patient did vomit a couple of times.
Second dose was given at a three week interval instead of the four week interval. This mistake was caught after the vaccine was administered, but did not result in any adverse reaction.
itching, starting with the arms and went to the legs and the trunk. Hot flushed ears. Tiny red pin point red rash to the inside of arm and legs. Gave benadryl 50mg for treatment. Partial resolution of symptoms.
Symptoms began on day seven with redness, by day 14, red, bumpy, swollen, itchy, hot, is about 8" long at day 14. Today feels like it is starting to ease up some.
fatigue, stayed in bed most of day after vaccination and during therapy oxygen sats dropped to 82 % on Room air, needed to start oxygen, HR 101, R 36, mild non productive cough, mild SOB, T 99.5   Oxygen administered at 2 liters from 1/7 at 220 pm til 1/8 0930 off oxygen sats 95%, guaifenisin 5 ml given 1/7/21 at bedtime _history of taking this in evening already GNP updated and ordered labs and CXR and oxygen via email/phone communication  Back to baseline 1/8 by mid morning, oxygen off and performing in therapy per prior (1/6 level and has since shown steady improvement in therapy as expected with rehab stay.
Muscle twitching began under left eye on March 3rd at 11am. Control of left eyelid was lost by March 3rd at 6pm Left side smile and chewing were adversely affected by March 3rd at 6pm. Symptoms continue to persist Note:  I haven't suffered from any headaches or dizziness or trouble thinking. Everything below the mouth is fine. My balance is fine.
Case number PHEH2012US018679 is an initial spontaneous report received from a health care professional on 05 Sep 2012 with a follow up information received on 16 Oct 2012: This report refers to a 17-year-old male patient. His vaccination history included administration of MENVEO (batch number: not reported) on 16 Dec 2007 which was well tolerated. His concomitant medications included influenza vaccine (unknown manufacturer, batch number: 44531AA) and GARDASIL (unknown manufacturer, batch number: H009746) at doses of 0.5 ml intramuscularly on 04 Sep 2012. He was vaccinated with MENVEO (batch number: M11082 and expiry date: 31 May 2014) intramuscularly on to right arm on 04 Sep 2012. This vaccine had reached up to 11 degree Celsius for 30 to 60 minutes due to power outage. It was reported that vaccine was stable and was okay to administer. No adverse event was reported following this administration error. Follow up information received on 16 Oct 2012: Patient demographics (height and weight), vaccination history, concomitant vaccines and route and site of suspect vaccine updated.
Patient complained of burning sensation at site of injection.  Claimed area had erythema and mild swelling.  Erythema and swelling has subsided but area is tender to the touch.
Extreme weakness, tiredness, fatigue, severe low back pain, fever, body aches, chills, headaches, lightheaded, near fainting, tachycardia, diaphoresis, tingling in feet, nausea. Symptoms began on Oct 5th and have been progressively worsened. Went to my PCP who ordered CBC, cmet, UA, sed rate and prescribed a Medrol dose pak and Levaquin prophylactically. All labs were normal. As of today I am still sick with all of the above symptoms despite finishing the medications. I have missed several days of work this past week due to nearly passing out at work from these symptoms.
Swelling and redness of upper arm about 48 hours after vaccine administration. Fever as well.
After one day, injection site turned red and itchy but cleared up after three days.  Then again, one week later, injection site became red and itchy and somewhat warm to touch.  Used anti-itch medication that helped somewhat.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 87-year-old female patient who received SHINGRIX for prophylaxis. On 31st October 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 1st November 2018, 1 days after receiving SHINGRIX, the patient experienced injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site erythema and injection site swelling were recovering/resolving. It was unknown if the reporter considered the injection site erythema and injection site swelling to be related to SHINGRIX. Additional details were reported as follows: The patient received the vaccine on the left arm. The pharmacist reported that, the patient experienced redness with a raised area at the injection site that was growing down to her arm towards the elbow. On an unknown date, the patient planned to follow-up with her physician. The limited information was provided. The pharmacist wanted to be transferred to medical information.
Resident sustained an episode of chest pain for which he refused medication intervention or emergency treatment following his vaccination. Chest pain resolved its self in an unknown amount of time with no interventions.
patient was in bipoc house hold, parent signed consent form.   noticed after booster was given that patient was under 18 y/o
Significantly worse gastroparesis. It?s sent me to the ER multiple times, 3 days in a row, because my stomach no longer empties. It?s been 3 days since I?ve been able to eat, and it?s gotten progressively worse. It was fully mild and manageable up until the 24 hours after the vaccine. I am currently admitted to the hospital preparing to get a feeding tube inserted so I can bypass the stomach completely. This is my 7th vaccine dose, and all of them have affected me neurologically, but this is the first time it?s affected the gastroparesis aspect of my neurology. I am completely unable to eat or drink now. I have no idea if it will resolve on its own or not.
This spontaneous report as received from a registered nurse refers to a 17 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 20-SEP-2017, the patient was vaccinated with improperly stored VAQTA (dosing details were not reported) (lot # N008823, expiry date: 26-MAY-2018) and GARDASIL 9 (dosing details were not reported) (lot # N019923, expiry date: 28-APR-2019) for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA007011: US-009507513-1709USA007012: US-009507513-1709USA007013: US-009507513-1709USA007014: US-009507513-1709USA000054.
Patient received her flu vaccination (Afluria Quadrivalent prefilled syringe) on 10/16/20.  The next morning patient awoke with pain in her lower back and progressed throughout the day. The mornings tend to be worse on pain level.  The pain is usually dull but with movement the pain can become very sharp.  Due to the pain she messaged the doctor on 10/19/20 and was scheduled for a telephone visit  on 10/20/20.  Patient was prescribed celecoxib for pain and inflammation and cyclobenzaprine for  muscle tension and tightness.